ITGAL / CD11a

CD11a antibody LS-C112442 is an FITC-conjugated rat monoclonal antibody to mouse CD11a (ITGAL). Validated for Flow, Func, IHC and IP.

Antibodies Primary

Article No

LS-C112442-0.1

Species Reactivity

mouse

Size

0.1 mg

Clone

M17/4

Source / Host

rat

Shipping Information

RT

Application

FA, FC, IHC, IP

Article No

LS-C112442-0.1

Species Reactivity

mouse

Size

0.1 mg

Clone

M17/4

Source / Host

rat

Shipping Information

RT

Application

FA, FC, IHC, IP

Specifications

NCBI Number 3683
Application FA, FC, IHC, IP
Article No LS-C112442-0.1
Country Availability SE, FI, DK, NO, FO, GL
Clone M17/4
Clone Type monoclonal
Concentration 0.5 mg/ml
Conjugation FITC
Description CD11a antibody LS-C112442 is an FITC-conjugated rat monoclonal antibody to mouse CD11a (ITGAL). Validated for Flow, Func, IHC and IP.
Supplier LifeSpan Biosciences
Entrez Gene ID 3683
Gene Symbol ITGAL
Immunogen C57BL/6 mouse splenic secondary cytotoxic T lymphocytes.
Isotype IgG2a
Notes CD11a antibody LS-C112442 is an FITC-conjugated rat monoclonal antibody to mouse CD11a (ITGAL). Validated for Flow, Func, IHC and IP.
Alias Names ITGAL, CD11A, Integrin alpha-L, LFA-1 alpha, LFA-1A, Integrin gene promoter, Alpha polypeptide), CD11a antigen, LFA-1, LFA1A
Product Type Antibodies Primary
Protocol Suggested working concentration is 3 ug/ml. Indicated dilution is recommended starting point for use of this product. Working concentrations should be determined by the investigator.
Purification Protein G purified
Shipping Information RT
Size 0.1 mg
Source / Host rat
Species Reactivity mouse
Storage 4°C
Substrate / Buffer PBS, pH 7.4, 15 mM Sodium Azide
Technical Specifications The rat monoclonal antibody M17/4 reacts with CD11a (alpha-subunit of murine LFA-1), a 180 kDa type I transmembrane glycoprotein expressed on B and T lymphocytes, monocytes, macrophages, neutrophils, basophils and eosinophils.
Product Page Updated 2024-04-12T06:35:05.844Z

Documentation

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more